home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Spruce Biosciences, Inc. - Common Stock (NQ:SPRB)

63.63 -2.38 (-3.61%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Spruce Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Why Smith & Wesson Brands Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗

September 08, 2023

Gainers Impel Pharmaceuticals Inc. (NASDAQ: IMPL) rose 41.3% to $0.54 in pre-market trading after falling 4% on Thursday.

Via Benzinga

Adobe To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Friday ↗

September 08, 2023

B of A Securities cut the price target for DigitalOcean Holdings, Inc. (NYSE: DOCN) from $47 to $25. B of A Securities analyst Wamsi Mohan downgraded the stock from Buy to Underperform. DigitalOcean...

Via Benzinga

Spruce Biosciences to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

August 28, 2023

From Spruce Biosciences

Via Business Wire

Expert Ratings for Spruce Biosciences ↗

August 16, 2023

Via Benzinga

Analyst Expectations for Spruce Biosciences's Future ↗

May 16, 2023

Via Benzinga

4 Analysts Have This to Say About Spruce Biosciences ↗

March 23, 2023

Via Benzinga

Spruce Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate Updates

August 14, 2023

From Spruce Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 27, 2023

Via Benzinga

Spruce Biosciences Announces Acceptance of Abstract for Presentation at the Annual Meeting of the Endocrine Society (ENDO 2023)

June 12, 2023

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences Appoints Percival Barretto-Ko to Board of Directors

May 25, 2023

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences to Participate in the Jefferies Healthcare Conference

May 24, 2023

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences Honored at CARES Foundation 15th Annual Everyone CARES Gala

May 22, 2023

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences Reports First Quarter 2023 Financial Results and Provides Corporate Updates

May 15, 2023

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting

May 04, 2023

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences to Participate in May Investor Conferences

May 02, 2023

From Spruce Biosciences, Inc.

Via Business Wire

89bio To Rally 265%? Here Are 10 Other Analyst Forecasts For Thursday ↗

March 23, 2023

Baird cut the price target for Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) from $14 to $11. Baird analyst Justin Kleber maintained an Outperform rating. Petco Health and Wellness shares rose...

Via Benzinga

Spruce Biosciences Reports Full Year 2022 Financial Results and Provides Corporate Updates

March 16, 2023

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences to Participate in the Oppenheimer 33rd Annual Healthcare Conference

February 28, 2023

From Spruce Biosciences, Inc.

Via Business Wire

$7M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying ↗

February 22, 2023

The Dow Jones closed lower by around 700 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 22, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 09, 2023

Via Benzinga

Spruce Biosciences Announces $53.6 Million Private Placement Financing

February 09, 2023

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences to Participate in the SVB Securities Global Biopharma Conference

February 01, 2023

From Spruce Biosciences, Inc.

Via Business Wire

Peering Into Spruce Biosciences's Recent Short Interest ↗

January 09, 2023

Spruce Biosciences's (NASDAQ:SPRB) short percent of float has risen 17.3% since its last report. The company recently reported that it has 588 thousand shares sold short, which is 3.39% of all regular...

Via Benzinga

Spruce Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023

January 09, 2023

From Spruce Biosciences, Inc.

Via Business Wire

Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket ↗

January 09, 2023

Gainers CinCor Pharma, Inc. (NASDAQ: CINC) rose 140.2% to $28.30 in pre-market trading after AstraZeneca announced plans to buy the company for up to $1.8 billion.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 06, 2023

Via Benzinga

Dow Jumps 700 Points; S&P 500 Rises Over 2% ↗

January 06, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 700 points on Friday.

Via Benzinga

Spruce Biosciences (NASDAQ: SPRB) Enters Into Collaboration with Kaken Pharmaceutical to Develop Tildacerfont for CAH in Japan

January 06, 2023

Spruce Biosciences, Inc. (NASDAQ: SPRB) is engaged as a late-stage biopharmaceutical company, which is focused on the research, development and

Via Spotlight Growth

Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 06, 2023

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com